Research ArticleTENDINOPATHY
Targeting the NF-κB signaling pathway in chronic tendon disease
- Adam C. Abraham1,*,
- Shivam A. Shah2,*,
- Mikhail Golman3,
- Lee Song1,
- Xiaoning Li1,
- Iden Kurtaliaj3,
- Moeed Akbar4,
- Neal L. Millar4,
- Yousef Abu-Amer5,6,
- Leesa M. Galatz7 and
- Stavros Thomopoulos1,3,†
- 1Department of Orthopedic Surgery, Columbia University, 650 W 168th St, New York, NY 10032, USA.
- 2Department of Biomedical Engineering, Washington University in St. Louis, 1 Brookings Drive, St. Louis, MO 63130, USA.
- 3Department of Biomedical Engineering, Columbia University, 1210 Amsterdam Ave, New York, NY 10027, USA.
- 4Institute of Infection, Immunity and Inflammation, College of Medicine, Veterinary and Life Sciences, University of Glasgow, 120 University Ave., Glasgow, Scotland G12 8TA, UK.
- 5Departments of Orthopedic Surgery and Cell Biology and Physiology, Washington University in St. Louis, 660 S. Euclid Ave., St. Louis, MO 63110, USA.
- 6Shriners Hospital for Children, 4400 Clayton Ave, St. Louis, MO 63110, USA.
- 7Department of Orthopedic Surgery, Mount Sinai, 5 E 98th St., New York, NY 10029, USA.
- ↵†Corresponding author. Email: sat2{at}columbia.edu
See allHide authors and affiliations
Science Translational Medicine 27 Feb 2019:
Vol. 11, Issue 481, eaav4319
DOI: 10.1126/scitranslmed.aav4319
